Navigation Links
Stereotaxis Appoints Industry Veteran as Head of EMEA Sales and Operations
Date:10/28/2010

herently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products in the marketplace, the effect of global  economic conditions on the ability and willingness of customers to purchase our systems and the timing of such purchases, competitive factors, changes resulting from the recently enacted healthcare reform in the U.S., including changes in government reimbursement procedures, dependence upon third-party vendors, timing of regulatory approvals, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that the Company will recognize revenue related to its purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of the Company's control. In addition, these orders and commitments may be revised, modified, delayed or canceled, either by their express terms, as a result of negotiations, or by overall project changes or delays.


'/>"/>
SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
2. Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank
3. Stereotaxis Announces Public Offering of Common Stock
4. Stereotaxis Announces Pricing of $26 Million Common Stock Offering
5. Stereotaxis Announces Underwriters Exercise of Over-Allotment Option
6. Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter
7. Stereotaxis System Procedure Featured on NBCs The TODAY Show
8. Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter
9. Stereotaxis Installs First System in Taiwan
10. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
11. Stereotaxis Announces Vdrive(TM), a New Technology for Remote Navigation of Diagnostic Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Columbia , May 5, 2015  InMed ... clinical stage biopharmaceutical company that specializes in developing ... former GW Pharmaceuticals financier, investor, and Non-Executive Director, ... InMed as Strategic Advisor with primary responsibility for ... role, Mr. Mountford will leverage his previous success ...
(Date:5/4/2015)... VANCOUVER, British Columbia , May 4, ... announced today that it will report its first quarter ... management will host a conference call and live webcast ... of financial results, clinical development programs and a general ... log on to the Investor Relations page of the ...
(Date:5/4/2015)...  Amgen (NASDAQ: AMGN ) will present at the ... on Thursday, May 7, 2015, at the InterContinental in ... vice president of Global Commercial Operations at Amgen, will present ... accessed from the Events Calendar on Amgen,s website, www.amgen.com ... be available on Amgen,s website for 90 days following the ...
Breaking Medicine Technology:InMed Engages Peter Mountford as Strategic Advisor 2InMed Engages Peter Mountford as Strategic Advisor 3InMed Engages Peter Mountford as Strategic Advisor 4Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference 2
... 10, 2010 Mylan Inc. (Nasdaq: MYL ... conversion rate applicable to its 6.50% Mandatory Convertible Preferred ... common stock of the company effective as of November ... the governing provisions of the company,s Amended and Restated ...
... Pharmaxis, a global specialty pharmaceutical company focused on therapeutic ... (mannitol inhalation powder) Bronchial Challenge Test Kit, at the ... Asthma and Immunology (ACAAI), November 11-16 in Phoenix, AZ. ... Drug Administration (FDA) on October 5, 2010, ARIDOL is ...
Cached Medicine Technology:Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 2Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 3Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 4Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 5
(Date:5/4/2015)... (PRWEB) May 05, 2015 The ... Gloria M. Betancourt as a 2015-2016 inductee into ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... present Gloria with this important honor," said NAPW President ...
(Date:5/4/2015)... 2015 Every Friday afternoon at A ... in Southwest Michigan, patients and staff gather in the ... the rehabilitation program and to gain encouragement and inspiration ... , One by one, those patients who have completed ... their certificates and to share a bit about their ...
(Date:5/4/2015)... 2015 Global Vision, the industry ... today announced that it will showcase Proofware at ... Center, in Nashville Tennessee, May 04 and May ... true all-in-one we-based packaging inspection suite, giving enterprise-wide ... of their brand copy and artwork. Proofware offers ...
(Date:5/4/2015)... Leonardo J. Lozada, M.D., Saint Luke’s ... and William C. Daniel, M.D., Saint Luke’s Health System ... from the Secretary of the Air Force to attend ... Air War College, Maxwell Air Force Base, Alabama. The ... senior U.S. and international officers and their civilian counterparts ...
(Date:5/4/2015)... May 04, 2015 Milton Hershey School® ... 2015 Alumnus of the Year, recognizing his commitment to ... philanthropy he sets for MHS students. , “Dr. Graves ... happen when children are provided a top-notch education, a ... their passions,” said Pete Gurt ’85, president of MHS. ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Gloria Betancourt, Receptionist at Consulate Health Care, into its 2015-2016 VIP Woman of the Year Circle 2Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2
... announced the approval of a new antifungal drug, for ... new drug called Eraxis, // is indicated in the ... ,The improved performance of Eraxis compared to ... have supported the approval. The drug can also be ...
... quite a trend setter of sorts. Now, BT Offices and ... // that smoking is banned in the BT premises as ... 26. Importantly, this move might encourage “anti-smoking” initiatives in other ... this announcement, which will surely set a precedent. Now this ...
... sex determination gene, that plays a crucial role in deciding ... (embryo with SRY gene develops into a male), could explain ... SRY protein, required for formation of testes is also produced ... Prince Henry's Institute and University of California. ,The ...
... infected by bird flu in northwestern Germany has been steadily ... // About 2 of the 103 cases were identified outside ... and troops have been involved in collection of carcasses. ... harbor the deadly virus. The Institute for Animal Health in ...
... reduce the harmful effects caused to babies by mothers who ... University. Foetal Alcohol Syndrome (FAS) results in mental retardation in ... ,The reserachers say that a drug called nicotinamide ... particular syndrome. The researchers arrived at this conclusion after successful ...
... foundation stone to construct a world-class cancer hospital and research ... at Rajarhat,// at the cost of Rs. 1.2 billion. ... would come up on a 10-acre plot, West Bengal Chief ... after laying the foundation stone for the project scheduled to ...
Cached Medicine News:Health News:Sex Determination Gene Blamed For High Incidence Of Parkinson’s In Me 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: